New skin gel tested against standard melasma treatment
NCT ID NCT07345507
Summary
This study compared two creams for treating melasma, a common skin condition causing dark patches. Thirty-four adults with melasma applied either a standard triple-combination cream or a new gel containing metformin to their face nightly for 12 weeks. Researchers measured which treatment was more effective at reducing the dark patches and which was better tolerated by the skin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELASMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
JPMC
Karachi, Sindh, 7550, Pakistan
Conditions
Explore the condition pages connected to this study.